LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Biodegradable Plastic Implants for Blood Vessel Repair

By LabMedica International staff writers
Posted on 12 May 2015
Image: Gross examination of an explanted TPU conduit after six months shows a white shiny inner surface without evidence of clot formation (Photo courtesy of Medical University of Vienna).
Image: Gross examination of an explanted TPU conduit after six months shows a white shiny inner surface without evidence of clot formation (Photo courtesy of Medical University of Vienna).
A new generation of artificial blood vessels gradually degrades as it is replaced by endogenous tissue that restores full biological function.

Investigators at Vienna University of Technology and Vienna Medical University worked with a type of biodegradable plastic known as thermoplastic polyurethane (TPU), which displays the adequate biomechanical strength and wall structure needed to promote rapid host remodeling.

In a study conducted on a group of 34 rats they investigated the in vitro and in vivo biocompatibility of thin host-vessel-matched grafts formed from hard-block biodegradable TPU. Expanded polytetrafluoroethylene (ePTFE) conduits served as control grafts in 34 other rats. Grafts were analyzed by various techniques after retrieval at different time points (one week; 1, 6, 12 months).

Results published in the January 1, 2015, issue of the journal Acta Biomaterialia revealed that TPU grafts showed significantly increased endothelial cell proliferation in vitro. Population by host cells increased significantly in the TPU conduits within one month of implantation. After long-term implantation, all the TPU implants, but only 93% of the ePTFE conduits, were expanded and unblocked with no signs of aneurysmal dilatation. Substantial remodeling of the degradable grafts was observed but varied between subjects. Intimal hyperplasia was found in 29% of the ePTFE conduits but not in the TPU implants.

First author Dr. Helga Bergmeister, professor of surgery at Vienna Medical University, said, "The rats' blood vessels were examined six months after insertion of the vascular prostheses. We did not find any aneurysms, thromboses or inflammation. Endogenous cells had colonized the vascular prostheses and turned the artificial constructs into natural body tissue."

Related Links:

Vienna University of Technology  
Vienna Medical University


Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Laboratory Software
ArtelWare
Homocysteine Quality Control
Liquichek Homocysteine Control

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more